What does it mean to take a moonshot in medical research?
For BrightFocus Foundation in Clarksburg, Maryland, it means daring to imagine a world where devastating diseases like Alzheimer’s, macular degeneration, and glaucoma are preventable and curable.
It means investing in bold, innovative research that pushes the boundaries of what’s possible in neuroscience and vision science.
As part of our 2025 Changemakers initiative, Full Sail Media is proud to highlight the extraordinary work of this vital research organization that has been advancing scientific discovery for over 50 years.
A Legacy of Scientific Innovation
Founded in 1973, just four years after humans first walked on the moon, BrightFocus Foundation emerged with the same ambitious spirit that defined the space race.
Their mission was clear: fund critical research to find cures for the most pressing health challenges of our time.
From their first breakthrough supporting the development of the artificial heart in 1982 to today’s cutting-edge research in Alzheimer’s, macular degeneration, and glaucoma, BrightFocus has consistently backed the kind of innovative, “high-risk, high-reward” science that leads to game-changing discoveries.
The Power of Early Support
One of BrightFocus Foundation’s most remarkable strengths is their ability to identify and support promising research in its earliest stages.
Their track record includes providing critical early funding to multiple Nobel Prize winners and members of the National Academy of Medicine.
Consider Dr. Stanley Prusiner, who received BrightFocus funding for his groundbreaking work on prions—research that would later earn him the 1997 Nobel Prize in Physiology or Medicine. Or Dr. Paul Greengard, whose BrightFocus-funded experiments led to discoveries about nerve cell communication that earned him the 2000 Nobel Prize.
These success stories highlight BrightFocus’s role in nurturing innovative ideas that might otherwise go unexplored.
By supporting scientists at critical early stages of their careers and research, they help turn promising hypotheses into life-changing treatments.
More Than Just Research Funding
What sets BrightFocus apart is their comprehensive approach to advancing scientific discovery and public health. Their work encompasses:
- Funding exceptional scientific research worldwide through their flagship programs:
- Providing expert information and resources to patients and families affected by these diseases
- Supporting early-career scientists through educational workshops and grants
- Promoting health equity in research to better prevent, treat, and cure mind and sight diseases
- Connecting patients with clinical trials and research opportunities
Over the past five decades, BrightFocus has invested nearly $300 million in research grants to more than 6,000 scientists across 25 countries.
This funding has catalyzed thousands of scientific breakthroughs, leading to life-enhancing treatments and diagnostic tools.
Innovation in Action
BrightFocus continues to drive breakthrough discoveries that are transforming patient care. Recent achievements include:
- Development of the first-ever blood test for Alzheimer’s disease, now in use in the United States and Europe
- Creation of artificial intelligence models that can detect early signs of Alzheimer’s through retinal scans
- Pioneering research in cell transplantation that could restore vision lost to glaucoma
- Groundbreaking studies linking sleep quality to Alzheimer’s risk and progression
Their commitment to innovation has earned them recognition from the U.S. Department of Defense and other prestigious institutions, highlighting the far-reaching impact of their work on public health.
Learn more about the work that BrightFocus provides at www.brightfocus.org
